Skip to content

Author

Julia C. Lecher

We have 2 of 23 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A novel proviral mechanism for the ISG, Shiftless, during human coronavirus infection

As highly pathogenic human coronaviruses continue to emerge from zoonotic sources, understanding how host intrinsic immune responses control infection is critical for preventing severe disease. The interferon (IFN) pathway induces antiviral effectors, including the interferon-stimulated gene (ISG) Shiftless (SHFL), whi...

Taylor M. Shue, Georgios Mourtzouchos, Dar-Yin Li et al. · 0 citations
Open access Jul 2026

The 5′-Isobutyryl Ester Prodrug of 4′-Thiouridine Inhibits SARS-CoV‑2 Replication in Culture and in a Syrian Hamster Infection Model

iBu TU is highlighted as a promising oral antiviral candidate for treating SARS-CoV-2 infection and significantly reduced viral loads and improved lung health without adverse effects in a Syrian hamster model infected with SARS-CoV-2.

Zhe Chen, F. Amblard, M. Kasthuri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.